|
1.
|
Ravenda V, Manette C, Lemmens R, Mariani
AM, Struvay N and Reginster JY: Prevalence and impact of
osteoarthritis and osteoporosis on health-related quality of life
among active subjects. Aging Clin Exp Res. 19:55–60. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Jinks C, Jordan K and Croft P:
Osteoarthritis as a public health problem: the impact of developing
knee pain on physical function in adults living in the community:
(KNEST 3). Rheumatology (Oxford). 46:877–881. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Yoshimura N, Muraki S, Oka H, Mabuchi A,
En-Yo Y, Yoshida M, Saika A, Yoshida H, Suzuki T, Yamamoto S,
Ishibashi H, Kawaguchi H, Nakamura K and Akune T: Prevalence of
knee osteoarthritis, lumbar spondylosis, and osteoporosis in
Japanese men and women: the research on osteoarthritis/osteoporosis
against disability study. J Bone Miner Metab. 27:620–628. 2009.
View Article : Google Scholar
|
|
4.
|
Eccles M, Freemantle N and Mason J: North
of England evidence-based guidelines development project: summary
guidelines for non-steroidal anti-inflammatory drugs versus basic
analgesia in treating the pain of degenerative arthritis. North of
England Non-steroidal Anti-inflammatory Drug Guidelines Development
Group. BMJ. 317:526–530. 1998.
|
|
5.
|
Wieland HA, Michaelis M, Kirschbaum BJ and
Rudolphi KA: Osteoarthritis: an untreatable disease? Nat Rev Drug
Discov. 4:331–344. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Rashad S, Revell P, Hemingway A, Low F,
Rainford K and Walker F: Effect of non-steroidal anti-inflammatory
drugs on the course of osteoarthritis. Lancet. 2:519–522. 1989.
View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Adams ME, Lussier AJ and Peyron JG: A
risk-benefit assessment of injections of hyaluronan and its
derivatives in the treatment of knee osteoarthritis. Drug Saf.
23:115–130. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Eisenberg DM, Davis RB, Ettner SL, Appel
S, Wilkey S, Van Rompay M and Kessler RC: Trends in alternative
medicine use in the United States, 1990–1997: results of a
follow-up national survey. JAMA. 280:1569–1575. 1998.
|
|
9.
|
Rao JK, Mihaliak K, Kroenke K, Bradley J,
Tiemey WM and Weinberger M: Use of complementary therapies for
arthritis among patients of rheumatologists. Am Intern Med.
131:409–416. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Astin JA: Why patients use alternative
medicine: results of a national study. JAMA. 279:1548–1553. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Bellamy N and Buchanan WW: Outcome
measurement in osteoarthritis clinical trials: the case for
standardization. Clin Rheumatol. 3:293–305. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Lequesne M, Brandt K, Bellamy N, Moskowitz
R, Menkes CJ, Pelletier JP and Altman R: Guidelines for testing
slow acting drugs in osteoarthritis. J Rheumatol Suppl. 41:65–71.
1994.PubMed/NCBI
|
|
13.
|
Pavelká K, Gatterová J, Olejarová M,
Machacek S, Giacovelli G and Rovati LC: Glucosamine sulfate use and
delay of progression of knee osteoarthritis. A 3-year, randomized,
placebo-controlled, double-blind study. Arch Intern Med.
162:2113–2123. 2002.PubMed/NCBI
|
|
14.
|
Reginster JY, Deroisy R, Rovati LC, Lee
RL, Lejeune E, Bruyere O, Giacovelli G, Henrotin Y, Dacre JE and
Gossett C: Long-term effects of glucosamine sulfate on
osteoarthritis progression: a randomised, placebo-controlled
clinical trial. Lancet. 357:251–256. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
McAlindon TE, La Valley MP, Gulin JP and
Felson DT: Glucosamine and chondroitin for treatment of
osteoarthritis: a systematic quality assessment and meta-analysis.
JAMA. 283:1469–1475. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Richy F, Bruyere O, Ethgen O, Cucherat M,
Henrotin Y and Reginster JY: Structural and symptomatic efficacy of
glucosamine and chondroitin sulfate in knee osteoarthritis. A
comprehensive meta-analysis. Arch Intern Med. 163:1514–1522. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Clegg DO, Reda DJ, Harris CL, Klein MA,
O'Dell JR, Hooper MM, Bradley JD, Bingham CO III, Weisman MH,
Jackson CG, Lane NE, Cush JJ, Moreland LW, Schumacher HR Jr, Oddis
CV, Wolfe F, Molitor JA, Yocum DE, Schnitzer TJ, Furst DE, Sawitzke
AD, Shi H, Brandt KD, Moskowitz RW and Williams HJ: Glucosamine,
chondroitin sulfate and the two in combination for painful knee
osteoarthritis. N Engl J Med. 354:795–808. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Natural Medicines Comprehensive Database:
8th edition. Therapeutic Research Faculty; Stockton, CA: 2006,
http://www.naturaldatabase.comuri.
(Accessed April 21, 2011).
|
|
19.
|
Rosenbaum CC, O'Mathúna DP, Chavez M and
Shields K: Antioxidants and anti-inflammatory dietary supplements
for osteoarthritis and rheumatoid arthritis. Altern Ther Health
Med. 16:32–40. 2010.PubMed/NCBI
|
|
20.
|
Loeser RF, Carlson CS, Del Carlo M and
Cole A: Detection of nitrotyrosine in aging and osteoarthritic
cartilage: correlation of oxidative damage with the presence of
interleukin-1 beta and with chondrocyte resistance to insulin-like
growth factor 1. Arthritis Rheum. 46:2349–2357. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Yudoh K, Nguyen T, Nakamura H,
Hongo-Masuko K, Kato T and Nishioka K: Potential involvement of
oxidative stress in cartilage senescence and development of
osteoarthritis: oxidative stress induces chondrocyte telomere
instability and down-regulation of chondrocyte function. Arthritis
Res Ther. 7:R380–R391. 2005. View
Article : Google Scholar
|
|
22.
|
Henrotin Y, Deby-Dupont G, Deby C, De
Bruyn M, Lamy M and Franchimont P: Production of active oxygen
species by isolated human chondrocytes. Br J Rheumatol. 32:562–567.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Henrotin Y, Deby-Dupont G, Deby C,
Franchimont P and Emerit I: Active oxygen species, articular
inflammation and cartilage damage. EXS. 62:308–322. 1992.PubMed/NCBI
|
|
24.
|
Martin JA and Buckwalter JA: Aging,
articular cartilage chondrocyte senescence and osteoarthritis.
Biogerontology. 3:257–264. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Usha PR and Naidu MU: Randomised,
double-blind, parallel, placebo-controlled study of oral
glucosamine, methylsulfonylmethane and their combination in
osteoarthritis. Clin Drug Invest. 24:353–363. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Kim LS, Axelrod LJ, Howard P, Buratovich N
and Waters RF: Efficacy of methylsulfonylmethane (MSM) in
osteoarthritis pain of the knee: a pilot clinical trial.
Osteoarthritis Cartilage. 14:286–294. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Ojewole JA: Antiinflammatory and analgesic
effects of Psidium guajava Linn. (Myrtaceae) leaf acqueous
extract in rats and mice. Methods Find Exp Clin Pharmacol.
28:441–446. 2006.
|
|
28.
|
McAlindon TE, Jaques P, Zhang Y, Hannan
MT, Aliabadi P, Weissman B, Rush D, Levy D and Felson DT: Do
antioxidant micronutrients protect against the development and
progression of knee osteoarthritis? Arthritis Rheum. 39:648–656.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
McAlindon TE, Felson DT, Zhang Y, Hannan
MT, Aliabadi P, Weissman B, Rush D, Wilson PW and Jacques P:
Relation of dietary intake and serum levels of vitamin D to
progression of osteoarthritis of the knee among participants in the
Framingham Study. Ann Intern Med. 125:353–359. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Rizkalla G, Reiner A, Bogoch E and Poole
AR: Studies on the articular cartilage proteoglycan aggrecan in
health and osteoarthritis. Evidence for molecular heterogeneity and
extensive molecular changes in disease. J Clin Invest.
90:2268–2277. 1992. View Article : Google Scholar
|
|
31.
|
Poole AR, Kobayashi M, Yasuda T, Laverty
S, Mwale F, Kojima T, Sakai T, Wahl C, El-Maadaway S, Webb G,
Tchetina E and Wu W: Type II collagen degradation and its
regulation in articular cartilage in osteoarthritis. Ann Rheum Dis.
61(Suppl 2): S78–S81. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Bassleer C, Ravati L and Frachimont P:
Stimulation of proteoglycan production by glucosamine sulfate in
chondrocytes isolated from human osteoarthritic articular cartilage
in vitro. Osteoarthritis Cartilage. 6:427–434. 1998. View Article : Google Scholar
|
|
33.
|
Piperno M, Reboul P, Hellio Le Graverand
MP, Peschard MJ, Annefeld M, Richard M and Vignon E: Glucosamine
sulfate modulates dysregulated activities of human osteoarthritic
chondrocytes in vitro. Osteoarthritis Cartilage. 8:207–212. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Lipiello L, Woodward J, Karpman R and
Hammand TA: In vivo chondroprotection and metabolic synergy of
glucosamine and chondroitin sulfate. Clin Orthop Relat Res.
381:229–240. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Oegema TR, Deloria LB, Sandy JD and Hart
DA: Effect of oral glucosamine on cartilage and meniscus in normal
and chymopapain-injected knee of young rabbits. Arthritis Rheum.
46:2495–2503. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Uebelhart D, Thonar EJ, Zhang J and
Williams JM: Protective effect of exogenous chondroitin 4,6-sulfate
in the acute degradation of articular cartilage in the rabbit.
Osteoarthritis Cartilage. 6(Suppl 1): S6–S13. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Christgau S, Henrotin Y, Tankó LB, Rovati
LC, Collette J, Bruyere O, Deroisy R and Reginster JY:
Osteoarthritic patients with high cartilage turnover show increased
responsiveness to the cartilage protecting effects of glucosamine
sulfate. Clin Exp Rheumatol. 22:36–42. 2004.
|
|
38.
|
Cibere J, Thorne A, Kopec JA, Singer J,
Canvin J, Robinson DB, Pope J, Grant E, Lobanok T, Ionescu M, Poole
AR and Esdaile JM: Glucosamine sulfate and cartilage type II
collagen degradation in patients with knee osteoarthritis:
randomized discontinuation trial results employing biomarkers. J
Rheumatol. 32:896–902. 2005.
|
|
39.
|
Mazières B, Hucher M, Zaïm M and Garnero
P: Effect of chondroitin sulfate in symptomatic knee
osteoarthritis: a multicentre, randomized, double-blind,
placebo-controlled study. Ann Rheum Dis. 66:639–645. 2007.
|
|
40.
|
Wells AF, Klareskog L, Lindblad S and
Laurent TC: Correlation between increased hyaluronan localized in
arthritic synovium and the presence of proliferating cells: a role
for macrophage-derived factors. Arthritis Rheum. 35:391–396. 1992.
View Article : Google Scholar
|
|
41.
|
Vilim V, Vytásek R, Olejárová M, Machácek
S, Gatterová J, Procházka B, Kraus VB and Pavelka K: Serum
cartilage oligomeric matrix protein reflects the presence of
clinically diagnosed synovitis in patients with knee
osteoarthritis. Osteoarthritis Cartilage. 9:612–618. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
42.
|
Kellgren JH and Lawrence JS: Radiological
assessment of osteoarthritis. Ann Rheum Dis. 16:494–502. 1957.
View Article : Google Scholar
|
|
43.
|
Akai M, Doi T, Fujino K, Iwaya T, Kurosawa
H and Nasu T: An outcome measure for Japanese people with knee
osteoarthritis. J Rheumatol. 32:1524–1532. 2005.PubMed/NCBI
|
|
44.
|
International Classification of
Functioning, Disability and Health. World Health Organization;
Geneva: 2001
|
|
45.
|
Akai M, Iwaya T, Kurosawa H, Doi T, Nasu
T, Hayashi K and Fujino K: Development of new disease-specific QOL
measure for patients with knee osteoarthritis. Japanese Knee
Osteoarthritis Measure (JKOM). J Phys Med. 16:55–62. 2005.
|
|
46.
|
Lewis B, Lewis D and Cumming G: The
comparative analgesic efficacy of transcutaneous electric nerve
stimulation and a nonsteroidal anti-inflammatory drug for painful
osteoarthritis. Br J Rheumatol. 33:455–460. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
47.
|
Pham T, Van der Heijde D, Lassere M,
Altman RD, Anderson JJ, Bellamy N, Hochberg M, Simon L, Strand V,
Woodworth T and Dougados M; OMERACT-OARSI: Outcome variables for
osteoarthritis clinical trial: the OMERACT-OARSI set of responder
criteria. J Rheumatol. 30:1648–1654. 2003.PubMed/NCBI
|
|
48.
|
Michel BA, Stucki G, Frey D, De Vathaire
F, Vignon E, Bruehlmann P and Uebelhart D: Chondroitins 4 and 6
sulphate in osteoarthritis of the knee: a randomized, controlled
trial. Arthiritis Rheum. 52:779–786. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
49.
|
Garnero P and Delmas PD: Biomarkers in
osteoarthritis. Curr Opin Rheumatol. 15:641–646. 2003. View Article : Google Scholar
|
|
50.
|
Kraus VB: Biomarkers in osteoarthritis.
Curr Opin Rheumatol. 17:641–646. 2005. View Article : Google Scholar
|
|
51.
|
Garnero P, Ayral X, Rousseau FC, Christgau
S, Sandell LJ, Dougados M and Delmas PD: Uncoupling of type II
collagen synthesis and degradation predicts progression of joint
damage in patients with knee osteoarthritis. Arthritis Rheum.
46:2613–2624. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
52.
|
Reijman M, Hazes JM, Bierma-Zeinstra SM,
Koes BW, Christgau S, Christiansen C, Uitterlinden AG and Pols HA:
A new marker for osteoarthritis: cross-sectional and longitudinal
approach. Arthritis Rheum. 50:2471–2478. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
53.
|
Poole AR, Ionescu M, Fitzcharles MA and
Billinghurst RC: The assessment of cartilage degradation in vivo:
development of an immunoassay for the measurement in body fluids of
type II collagen cleaved by collagenases. J Immunol Methods.
294:145–153. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
54.
|
Sharif M, George E, Shepstone L, Knudson
W, Thonar EJ, Cushnaghan J and Dieppe P: Serum hyaluronic acid
level as a predictor of disease progression in osteoarthritis of
the knee. Arthritis Rheum. 38:760–767. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
55.
|
Pavelka K, Forejtová S, Olejárová M,
Gatterová J, Senolt L, Spacek P, Braun M, Hulejová M, Stovicková J
and Pavelková A: Hyaluronic acid levels may have predictive value
for the progression of knee osteoarthritis. Osteoarthritis
Cartilage. 12:277–283. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
56.
|
Mazières B, Garnero P, Guéguen A, Abbal M,
Berdah L, Lequesne M, Nguyen M, Sallles JP, Vignon E and Dougados
M: Molecular markers of cartilage breakdown and synovitis at
baseline as predictors of structural progression of hip
osteoarthritis. The ECHODIAH Cohort. Ann Rheum Dis. 65:354–359.
2006.PubMed/NCBI
|
|
57.
|
Ayral X, Pickering EH, Woodworth TG,
Mackillop N and Dougados M: Synovitis: a potential predictive
factor of structural progression of medial tibiofemoral knee
osteoarthritis - results of a 1 year longitudinal arthroscopic
study in 422 patients. Osteoarthritis Cartilage. 13:361–367.
2005.
|
|
58.
|
Saari H, Sorsa T, Lindy O, Sumalainen K,
Halinen S and Konttinen YT: Reactive oxygen species as regulators
of human neutrophil and fibroblast interstitial collagenases. Int J
Tissue React. 14:113–120. 1992.PubMed/NCBI
|
|
59.
|
Saari H, Konttinen YT, Friman C and Sorsa
T: Differential effects of reactive oxygen species on native
synovial fluid and purified human umbrical cord hyaluronate.
Inflammation. 17:403–415. 1993. View Article : Google Scholar : PubMed/NCBI
|
